Your browser doesn't support javascript.
loading
Regulation of the Gene Expression of Airway MUC5AC Mucin through NF-κB Signaling Pathway by Artesunate, an Antimalarial Agent.
Kim, Kyung-Il; Hossain, Rajib; Ryu, Jiho; Lee, Hyun Jae; Lee, Choong Jae.
Afiliación
  • Kim KI; Department of Pharmacology, School of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.
  • Hossain R; Brain Korea 21 FOUR Project for Medical Science, Chungnam National University, Daejeon 35015, Republic of Korea.
  • Ryu J; Department of Pharmacology, School of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.
  • Lee HJ; Brain Korea 21 FOUR Project for Medical Science, Chungnam National University, Daejeon 35015, Republic of Korea.
  • Lee CJ; Department of Pharmacy, College of Pharmacy, Chungbuk National University, Cheongju 28644, Republic of Korea.
Biomol Ther (Seoul) ; 31(5): 544-549, 2023 Sep 01.
Article en En | MEDLINE | ID: mdl-37254459
ABSTRACT
In this study, artesunate, an antimalarial agent, was investigated for its potential effect on the gene expression of airway MUC5AC mucin. The human pulmonary epithelial NCI-H292 cells were pretreated with artesunate for 30 min and then stimulated with phorbol 12-myristate 13-acetate (PMA), for the following 24 h. The effect of artesunate on PMA-induced nuclear factor kappa B (NF-kB) signaling pathway was also examined. Artesunate inhibited the glycoprotein production and mRNA expression of MUC5AC mucins, induced by PMA through the inhibition of degradation of inhibitory kappa Bα (IkBα) and NF-kB p65 nuclear translocation. These results suggest artesunate suppresses the gene expression of mucin through regulation of NF-kB signaling pathway, in human pulmonary epithelial cells.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomol Ther (Seoul) Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomol Ther (Seoul) Año: 2023 Tipo del documento: Article
...